News & Updates
Filter by Specialty:
Nutritional status predicts treatment tolerability, mortality risk in IPF patients
The nutritional status of patients with idiopathic pulmonary fibrosis (IPF) has a significant impact on both treatment and outcome, suggests a study, noting that assessing the nutritional status offers helpful information for managing these individuals.
Nutritional status predicts treatment tolerability, mortality risk in IPF patients
10 Aug 2023
Camrelizumab plus chemo combo beneficial in Asian patients with advanced NSCLC
Adding camrelizumab to platinum-based chemotherapy in the neoadjuvant treatment setting appears to improve the rate of pathologic complete response (pCR) in Asian patients with stage IIIA or IIIB non–small cell lung cancer (NSCLC), with manageable toxicity, according to data from the phase II TD-FOREKNOW study.
Camrelizumab plus chemo combo beneficial in Asian patients with advanced NSCLC
10 Aug 2023
Change in gait speed predicts hospitalization, death in IPF patients
A considerable decline of >0.07 m/s in 4-metre gait speed (4MGS) over 6 months is associated with a higher risk of all-cause, nonelective hospitalization or death over the next 6 months in patients with a newly diagnosed idiopathic pulmonary fibrosis (IPF), suggests a study.
Change in gait speed predicts hospitalization, death in IPF patients
09 Aug 2023
Early life food allergy a red flag for later asthma, lung problems
Food allergy in infancy, regardless of whether it resolves, may affect lung development and contribute to poorer respiratory outcomes such as asthma and reduced lung function in childhood, as shown in a study.
